Drug Prices, Drug shortages Drug Prices and Shortages Jeopardize Patient Access to Quality Hospital Care May 22, 2024 By Bharath Krishnamurthy, Director, Health Analytics & Policy, Megha Parikh, Associate Director of Health Analytics and Policy
Hospital Data, Setting the Record Straight Unequal Transparency: How Hospitals Report More Data than Any Other Entity in the Health Care Sector Apr 17, 2024 By Bharath Krishnamurthy, Director, Health Analytics & Policy, Aaron Wesolowski, AHA Vice President of Research Strategy and Policy Communications
340B Drug Pricing Program New Error-Ridden 340B Study Misses the Mark Feb 7, 2024 By Bharath Krishnamurthy, Director, Health Analytics & Policy, Aimee Kuhlman, VP Advocacy Grassroots, Government Relations
Financial Management, Patient care and Information Margin Misconceptions: What do Break-even Hospital Margins Mean for Patient Care? Aug 1, 2023 By Bharath Krishnamurthy, Director, Health Analytics & Policy
Drug Prices Flawed Report Aims to Deflect Attention From Role Insurer PBMs Play in High Drug Costs Apr 25, 2023 By Mark Howell, Bharath Krishnamurthy, Director, Health Analytics & Policy
Drug Prices, Setting the Record Straight Flawed Report Aims to Deflect Attention From Role Insurer PBMs Play in High Drug Costs Apr 25, 2023 By Mark Howell, Bharath Krishnamurthy, Director, Health Analytics & Policy
340B Drug Pricing Program New PhRMA-led Coalition Seeks to Dismantle 340B and Undermine Access to Care for Patients Apr 5, 2023 By Bharath Krishnamurthy, Director, Health Analytics & Policy
340B Drug Pricing Program Restoring the 340B OPPS Payment Policy: Good for Patients, Good for Providers Sep 21, 2022 By Bharath Krishnamurthy, Director, Health Analytics & Policy, Aimee Kuhlman, VP Advocacy Grassroots, Government Relations
